Literature DB >> 7494826

Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.

H Sasaki1, Y Igarashi, T Nagano, K Nishida, J Nakamura.   

Abstract

PURPOSE: The purpose of this study was to investigate the improvement in corneal penetration of ophthalmic beta-blockers of various lipophilicities afforded by absorption promoters and to compare the corneal against conjunctival penetration in response to absorption promoters.
METHODS: The penetration of the beta-blockers, atenolol, carteolol, tilisolol, timolol, and befunolol, in the presence of absorption promoters, across the isolated corneal and conjunctival membranes of albino rabbits was measured using a two-chamber glass diffusion cell. EDTA, taurocholic acid, capric acid, and saponin were used as the absorption promoters.
RESULTS: The absorption promoters significantly increased the corneal permeability of most beta-blockers, especially the hydrophilic agents. The absorption promoters also enhanced the conjunctival permeability of beta-blockers, although their effect in promoting conjunctival penetration was less than that on corneal penetration. There was a differing penetration of instilled beta-blockers in the cornea and conjunctiva in response to absorption promoters. Capric acid and saponin showed significant promoting action on corneal penetration, but not on conjunctival penetration. Taurocholic acid had a significant effect on conjunctival penetration but not on corneal penetration. Saponin caused slight irritation.
CONCLUSIONS: Absorption promoters can improve the ocular delivery of beta-blockers and a selective use of absorption promoter can improve the extent and pathway of drug ocular absorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494826     DOI: 10.1023/a:1016203725128

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.

Authors:  P Ashton; S K Podder; V H Lee
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

Review 2.  Topical ocular drug delivery: recent developments and future challenges.

Authors:  V H Lee; J R Robinson
Journal:  J Ocul Pharmacol       Date:  1986

3.  Biophasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer- and surfactant-promoted miotic activity.

Authors:  V F Smolen; J M Clevenger; E J Williams; M W Bergdolt
Journal:  J Pharm Sci       Date:  1973-06       Impact factor: 3.534

4.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

5.  In vitro study on corneal permeability to bunazosin.

Authors:  A Kato; S Iwata
Journal:  J Pharmacobiodyn       Date:  1988-02

Review 6.  Ophthalmic beta-blockers since timolol.

Authors:  G D Novack
Journal:  Surv Ophthalmol       Date:  1987 Mar-Apr       Impact factor: 6.048

7.  Paracellular permeability of corneal and conjunctival epithelia.

Authors:  A J Huang; S C Tseng; K R Kenyon
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-04       Impact factor: 4.799

8.  Conjunctival penetration of insulin and peptide drugs in the albino rabbit.

Authors:  E Hayakawa; D S Chien; K Inagaki; A Yamamoto; W Wang; V H Lee
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

9.  Topically applied cyclosporine in azone prolongs corneal allograft survival.

Authors:  C Newton; B M Gebhardt; H E Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-02       Impact factor: 4.799

  9 in total
  8 in total

1.  Penetration of engineered antibody fragments into the eye.

Authors:  M A Thiel; D J Coster; S D Standfield; H M Brereton; C Mavrangelos; H Zola; S Taylor; A Yusim; K A Williams
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

3.  High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.

Authors:  J Ye; H Wu; Y Wu; C Wang; H Zhang; X Shi; J Yang
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

4.  Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.

Authors:  Marjan Nabili; Hetal Patel; Sankaranarayana P Mahesh; Ji Liu; Craig Geist; Vesna Zderic
Journal:  Ultrasound Med Biol       Date:  2013-02-13       Impact factor: 2.998

5.  Ocular tolerance of absorption enhancers in ophthalmic preparations.

Authors:  Pascal Furrer; Joachim Michael Mayer; Bernard Plazonnet; Robert Gurny
Journal:  AAPS PharmSci       Date:  2002

Review 6.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

7.  Ultrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study.

Authors:  Marjan Nabili; Aditi Shenoy; Shawn Chawla; Sankaranarayana Mahesh; Ji Liu; Craig Geist; Vesna Zderic
Journal:  J Ther Ultrasound       Date:  2014-03-31

Review 8.  Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles.

Authors:  Qing Zhao; Xin Luan; Min Zheng; Xin-Hui Tian; Jing Zhao; Wei-Dong Zhang; Bing-Liang Ma
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.